New Alzheimer's drug tested for safety in Early-Stage patients
NCT ID NCT04602624
Summary
This study tested the safety and side effects of an investigational drug called SAGE-718 in people with early memory problems or mild dementia due to Alzheimer's disease. It involved 26 participants and also looked at whether the drug had any effects on their thinking skills and mood. The main goal was to see if the drug was safe and well-tolerated before larger studies could be done.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ALZHEIMER DISEASE are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Sage Investigational Site
Phoenix, Arizona, 85044, United States
-
Sage Investigational Site
Redlands, California, 92374, United States
-
Sage Investigational Site
Miami, Florida, 33137, United States
-
Sage Investigational Site
St. Petersburg, Florida, 33713, United States
-
Sage Investigational Site
Decatur, Georgia, 30030, United States
-
Sage Investigational Site
Decatur, Georgia, 30033, United States
-
Sage Investigational Site
Gaithersburg, Maryland, 20877, United States
-
Sage Investigational Site
Farmington Hills, Michigan, 48334, United States
-
Sage Investigational Site
Omaha, Nebraska, 68130, United States
-
Sage Investigational Site
North Canton, Ohio, 44720, United States
Conditions
Explore the condition pages connected to this study.